SAB Biotherapeutics SABS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 1.76 | 12 | -60.52 | -10 | -29.64 | 30 |
| 2025Q1 | 1.36 | 21 | -21.94 | -5 | -12.63 | 38 |
| 2024Q4 | 3.79 | 26 | -36.25 | -11 | -23.26 | 44 |
| 2024Q3 | 2.70 | 37 | -24.93 | -10 | -17.89 | 54 |
| 2024Q2 | 3.10 | 46 | -14.83 | -7 | -11.01 | 62 |
| 2024Q1 | 4.54 | 53 | -9.13 | -5 | -6.47 | 71 |
| 2023Q4 | 6.88 | 57 | -63.01 | -23 | -40.72 | 84 |
| 2023Q3 | 6.30 | 15 | -29.18 | -5 | -16.00 | 28 |
| 2023Q2 | 8.30 | 20 | -31.19 | -7 | -17.62 | 35 |
| 2023Q1 | 4.40 | 24 | -26.52 | -7 | -15.72 | 43 |
| 2022Q4 | 5.90 | 31 | -25.53 | -8 | -15.23 | 51 |
| 2022Q3 | 7.01 | 31 | -20.89 | -7 | -12.67 | 53 |
| 2022Q2 | 14.50 | 37 | -12.19 | -5 | -7.54 | 59 |
| 2022Q1 | 37.60 | 41 | 2.47 | 1 | 1.34 | 67 |
| 2021Q4 | 78.10 | 39 | -12 | -11.77 | 79 | |
| 2021Q3 | -9 | 0 | -0.28 | 117 | ||
| 2021Q2 | 5 | -58.84 | -3 | -2.51 | 117 | |
| 2021Q1 | 5 | 6.41 | 1 | 1.62 | 117 | |
| 2020Q4 | 39 | 57 |